RadNet (FRA:PQIA) FCF Margin % : 9.02% (As of Dec. 2023)

View and export this data going back to 2013. Start your Free Trial

What is RadNet FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. RadNet's Free Cash Flow for the three months ended in Dec. 2023 was €35 Mil. RadNet's Revenue for the three months ended in Dec. 2023 was €385 Mil. Therefore, RadNet's FCF Margin % for the quarter that ended in Dec. 2023 was 9.02%.

As of today, RadNet's current FCF Yield % is 0.84%.

The historical rank and industry rank for RadNet's FCF Margin % or its related term are showing as below:

FRA:PQIA' s FCF Margin % Range Over the Past 10 Years
Min: -8.24 Med: 0.82 Max: 10.11
Current: 2.01

During the past 13 years, the highest FCF Margin % of RadNet was 10.11%. The lowest was -8.24%. And the median was 0.82%.

FRA:PQIA's FCF Margin % is ranked better than
63.84% of 224 companies
in the Medical Diagnostics & Research industry
Industry Median: -11.09 vs FRA:PQIA: 2.01

RadNet FCF Margin % Historical Data

The historical data trend for RadNet's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RadNet FCF Margin % Chart

RadNet Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

0.26

10.11

-5.41

-7.20

2.06

RadNet Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
FCF Margin %	Get a 7-Day Free Trial															-25.31	-5.97	7.09	-2.46	9.02

Competitive Comparison of RadNet's FCF Margin %

For the Diagnostics & Research subindustry, RadNet's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

RadNet's FCF Margin % Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, RadNet's FCF Margin % distribution charts can be found below:

* The bar in red indicates where RadNet's FCF Margin % falls into.

RadNet FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

RadNet's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	30.577	/	1482.45
	=	2.06 %

RadNet's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	34.79	/	385.491
	=	9.02 %

RadNet FCF Margin % Related Terms

Thank you for viewing the detailed overview of RadNet's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

RadNet (FRA:PQIA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » RadNet Inc (FRA:PQIA) » Definitions » FCF Margin %

Comparable Companies

SHC NEOG GH TWST NEO MYGN VCYT LAB OPK FLGT TMO DHR IQV XSWX:LONN IDXX A MTD ICLR ILMN WAT

Traded in Other Exchanges

RDNT:USA

Address

1510 Cotner Avenue, Los Angeles, CA, USA, 90025

Website

http://www.radnet.com

RadNet Inc is a national provider of diagnostic imaging services that operates in two business segments; Imaging Center segment provides physicians with imaging capabilities to facilitate the diagnosis and treatment of diseases and disorders. Services include magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy and other related procedures, and Artificial Intelligence segment develops and deploys clinical applications to enhance interpretation of medical images and improve patient outcomes with an emphasis on brain, breast, prostate, and pulmonary diagnostics. The company derives a majority of its revenue from the Imaging center segment.

RadNet (FRA:PQIA) Headlines

No Headlines